“Researchers found herpes viruses circulating in unvaccinated patients who had experienced COVID-19. In patients with chronic fatigue syndrome, antibody responses were stronger, signaling an immune system struggling to fight off the lingering viruses,” Fortune reported. “Such non-COVID-19 pathogens have been named as likely culprits behind chronic fatigue syndrome, also known as myalgic encephalomyelitis.”
The authors of the study wrote, “Anti-SARS-CoV-2 antibodies were analyzed in plasma and saliva from non-vaccinated people with chronic fatigue syndrome and healthy subjects.”
Advertisement
Anti-viral antibody fingerprints in saliva were used to detect virus reactivation.
Boost Antiviral Immune Responses While Treating Chronic Fatigue Syndrome
“SARS-CoV-2 infection even in its mild/asymptomatic form is a potent trigger for reactivation of latent viruses. This has not been shown before because the antibody elevation is not detected systemically in the circulation/plasma,” they wrote.
They concluded, “Our results highlight that treatment options directed to boost antiviral immune responses, may benefit patients with (chronic fatigue syndrome) by tuning the fine balance between latent virus reactivation and an appropriate immune response.”
Source: Medindia
